De Rucci Healthy Sleep Co., Ltd. (SHE:001323)
China · Delayed Price · Currency is CNY 27.18
-0.48 (-1.74%)
Feb 2, 2026, 3:04 PM CST
De Rucci Healthy Sleep Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 |
Operating Revenue | 5,405 | 5,522 | 5,516 | 5,757 | 6,416 | 4,420 |
Other Revenue | 80.7 | 80.7 | 62.35 | 55.31 | 64.86 | 32.82 |
| 5,486 | 5,603 | 5,579 | 5,813 | 6,481 | 4,452 | |
Revenue Growth (YoY) | -2.92% | 0.43% | -4.03% | -10.31% | 45.56% | 15.29% |
Cost of Revenue | 2,687 | 2,802 | 2,775 | 3,113 | 3,568 | 2,262 |
Gross Profit | 2,799 | 2,801 | 2,803 | 2,699 | 2,913 | 2,191 |
Selling, General & Admin | 1,813 | 1,713 | 1,709 | 1,769 | 1,911 | 1,394 |
Research & Development | 214.76 | 205.28 | 185.76 | 158.29 | 155.08 | 90.35 |
Other Operating Expenses | 46.03 | 40.51 | 36.3 | 46.99 | 46.81 | 36.92 |
Operating Expenses | 2,082 | 1,961 | 1,928 | 1,981 | 2,116 | 1,522 |
Operating Income | 717.43 | 840.48 | 875.48 | 718.6 | 797.17 | 668.64 |
Interest Expense | -20.15 | -17.88 | -8.79 | -9.28 | -10.85 | -2.6 |
Interest & Investment Income | 56.85 | 65.88 | 73.24 | 58.83 | 39.77 | 7.8 |
Currency Exchange Gain (Loss) | -4.13 | -4.13 | 0.83 | -5.34 | -6.55 | 4.15 |
Other Non Operating Income (Expenses) | -5.98 | -2.98 | -8.59 | -8.25 | -9.1 | -8.32 |
EBT Excluding Unusual Items | 744.03 | 881.38 | 932.17 | 754.56 | 810.44 | 669.68 |
Gain (Loss) on Sale of Investments | 68.75 | 21.42 | 0.39 | 0.74 | - | -0.09 |
Gain (Loss) on Sale of Assets | 1.76 | -8 | 7.17 | 29.31 | -4.52 | -0.69 |
Asset Writedown | -2.37 | -1.4 | -7.41 | -1.11 | -0.39 | -4.05 |
Other Unusual Items | 25.34 | 25.34 | 26.98 | 35.91 | 10.28 | -3.81 |
Pretax Income | 837.5 | 918.73 | 959.31 | 819.4 | 817.82 | 662.89 |
Income Tax Expense | 127.97 | 151.4 | 157.04 | 111 | 131.37 | 126.58 |
Earnings From Continuing Operations | 709.53 | 767.33 | 802.27 | 708.41 | 686.44 | 536.3 |
Minority Interest in Earnings | 2.4 | - | - | - | - | 0.03 |
Net Income | 711.92 | 767.33 | 802.27 | 708.41 | 686.44 | 536.34 |
Net Income to Common | 711.92 | 767.33 | 802.27 | 708.41 | 686.44 | 536.34 |
Net Income Growth | -11.70% | -4.35% | 13.25% | 3.20% | 27.99% | 61.06% |
Shares Outstanding (Basic) | 431 | 433 | 439 | 419 | 395 | 351 |
Shares Outstanding (Diluted) | 431 | 433 | 439 | 419 | 395 | 351 |
Shares Change (YoY) | -1.35% | -1.41% | 4.80% | 5.98% | 12.57% | - |
EPS (Basic) | 1.65 | 1.77 | 1.83 | 1.69 | 1.74 | 1.53 |
EPS (Diluted) | 1.65 | 1.77 | 1.83 | 1.69 | 1.74 | 1.53 |
EPS Growth | -10.49% | -2.99% | 8.07% | -2.62% | 13.69% | - |
Free Cash Flow | 618.2 | 709.84 | 1,539 | 25.7 | 226.43 | 530.18 |
Free Cash Flow Per Share | 1.44 | 1.64 | 3.50 | 0.06 | 0.57 | 1.51 |
Dividend Per Share | 1.359 | 1.591 | 0.909 | 1.818 | - | - |
Dividend Growth | -14.57% | 75.00% | -50.00% | - | - | - |
Gross Margin | 51.03% | 49.99% | 50.25% | 46.44% | 44.94% | 49.20% |
Operating Margin | 13.08% | 15.00% | 15.69% | 12.36% | 12.30% | 15.02% |
Profit Margin | 12.98% | 13.70% | 14.38% | 12.19% | 10.59% | 12.05% |
Free Cash Flow Margin | 11.27% | 12.67% | 27.59% | 0.44% | 3.49% | 11.91% |
EBITDA | 936.15 | 1,049 | 1,069 | 893.41 | 925.05 | 746.43 |
EBITDA Margin | 17.06% | 18.71% | 19.17% | 15.37% | 14.27% | 16.77% |
D&A For EBITDA | 218.72 | 208.1 | 193.93 | 174.81 | 127.89 | 77.79 |
EBIT | 717.43 | 840.48 | 875.48 | 718.6 | 797.17 | 668.64 |
EBIT Margin | 13.08% | 15.00% | 15.69% | 12.36% | 12.30% | 15.02% |
Effective Tax Rate | 15.28% | 16.48% | 16.37% | 13.55% | 16.06% | 19.10% |
Revenue as Reported | 5,486 | 5,603 | 5,579 | 5,813 | 6,481 | - |
Advertising Expenses | - | 768.93 | 753.11 | 756.49 | 831.77 | 588.93 |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.